Department of Surgery, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Colorectal Dis. 2019 Oct;21(10):1112-1119. doi: 10.1111/codi.14659. Epub 2019 May 23.
In patients who have undergone a polypectomy of a malignant rectal polyp without histopathological risk factors other than an involved or unclear resection margin, additional local excision is often performed. Evidence to support this approach is lacking. The aim of this systematic review and meta-analysis was to determine the outcome in terms of local recurrence, disease-free survival (DFS) and overall survival (OS) of additional local excision following incomplete polypectomy for low risk T1 rectal cancer.
A comprehensive search for published studies was performed. Only studies in which there was incomplete (or ≤ 1 mm) removal of pT1 rectal polyps or in which the resection plane could not be assessed were included. For each included study data on tumour stage, histological factors, surgical technique, local recurrence rate, 5-year DFS and 5-year OS were extracted. The PROSPERO registration number is CRD42017062702.
A total of 580 studies were retrieved by the search in the MEDLINE database, Embase and the Cochrane Library. After careful appreciation, four studies were included in the analysis, comprising 102 patients of whom the majority had undeterminable (Rx) resection margins. Local excision via transanal endoscopic microsurgery was reported most frequently. Only 1% of patients developed a local recurrence. One study reported 5-year DFS and 5-year OS of 96% and 87% respectively.
This study supports the use of additional local excision techniques for rectal cancer patients who underwent an incomplete polypectomy for a malignant rectal polyp in the absence of risk factors other than an uncertain resection margin.
在除切缘受累或不明确以外无其他组织病理学危险因素的恶性直肠息肉患者中,息肉切除术常需要追加局部切除。但目前缺乏支持这种方法的证据。本系统评价和荟萃分析旨在确定对于低危 T1 期直肠肿瘤,不完全息肉切除术(切除不完整或<1mm)后行追加局部切除的局部复发率、无病生存率(DFS)和总生存率(OS)。
全面检索了发表的研究。仅纳入不完全(或≤1mm)切除 pT1 直肠息肉或无法评估切缘的研究。对于每项纳入的研究,提取肿瘤分期、组织学因素、手术技术、局部复发率、5 年 DFS 和 5 年 OS 等数据。PROSPERO 注册号为 CRD42017062702。
通过对 MEDLINE 数据库、Embase 和 Cochrane 图书馆的检索,共检索到 580 项研究。经仔细评估,4 项研究纳入分析,共 102 例患者,其中多数为切缘不可评估(Rx)。经肛门内镜微创手术行追加局部切除的报道最多。仅有 1%的患者发生局部复发。有 1 项研究报告的 5 年 DFS 和 5 年 OS 分别为 96%和 87%。
本研究支持对于除切缘受累或不明确以外无其他组织病理学危险因素的恶性直肠息肉患者,行不完全息肉切除术时追加局部切除技术。